Key PointsAmgen’s revenue is growing at a good clip, and it could sustain that pace despite impending patent cliffs.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.